T. Gleason Shane's most recent trade in InspireMD Inc was a trade of 17,593 Common Stock done at an average price of $1.6 . Disclosure was reported to the exchange on Jan. 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| InspireMD Inc | Shane T. Gleason | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.62 per share. | 15 Jan 2026 | 17,593 | 1,174,664 (32%) | 0% | 1.6 | 28,553 | Common Stock |
| InspireMD Inc | Shane T. Gleason | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.65 per share. | 15 Jan 2026 | 12,395 | 1,149,077 (31%) | 0% | 1.7 | 20,464 | Common Stock |
| InspireMD Inc | Shane T. Gleason | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.57 per share. | 15 Jan 2026 | 8,411 | 1,166,253 (32%) | 0% | 1.6 | 13,239 | Common Stock |
| InspireMD Inc | Shane T. Gleason | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.65 per share. | 15 Jan 2026 | 5,000 | 1,144,077 (31%) | 0% | 1.7 | 8,250 | Common Stock |
| InspireMD Inc | Shane T. Gleason | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.66 per share. | 15 Jan 2026 | 4,781 | 1,161,472 (31%) | 0% | 1.7 | 7,956 | Common Stock |
| InspireMD Inc | Shane T. Gleason | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.59 per share. | 15 Jan 2026 | 2,955 | 1,192,257 (32%) | 0% | 1.6 | 4,710 | Common Stock |
| InspireMD Inc | Shane T. Gleason | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.58 per share. | 15 Jan 2026 | 2,909 | 1,197,462 (32%) | 0% | 1.6 | 4,593 | Common Stock |
| InspireMD Inc | Shane T. Gleason | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.63 per share. | 15 Jan 2026 | 2,900 | 1,141,177 (31%) | 0% | 1.6 | 4,730 | Common Stock |
| InspireMD Inc | Shane T. Gleason | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.61 per share. | 15 Jan 2026 | 2,250 | 1,195,212 (32%) | 0% | 1.6 | 3,627 | Common Stock |
| InspireMD Inc | Shane T. Gleason | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.60 per share. | 15 Jan 2026 | 2,000 | 1,139,177 (31%) | 0% | 1.6 | 3,208 | Common Stock |
| InspireMD Inc | Shane T. Gleason | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2026 | 453,390 | 1,200,371 (33%) | 12% | 0 | Common Stock | |
| InspireMD Inc | T. Gleason Shane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 238,625 | 514,365 (14%) | 6% | 0 | Common Stock | |
| InspireMD Inc | Shane T. Gleason | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 91,218 | 183,128 | - | - | Options to purchase common stock (right to buy) | |
| InspireMD Inc | Shane T. Gleason | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2023 | 19,290 | 275,740 (7%) | 0% | 0 | Common Stock | |
| InspireMD Inc | Shane T. Gleason | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2023 | 6,430 | 91,910 | - | - | Options to purchase common stock (right to buy) | |
| InspireMD Inc | Shane T. Gleason | VP Global Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 256,450 | 256,450 (7%) | 7% | 0 | Common Stock | |
| InspireMD Inc | Shane T. Gleason | VP Global Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 85,480 | 85,480 | - | - | Options to purchase common stock (right to buy) |